Skip to main content
. Author manuscript; available in PMC: 2024 Jul 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2021 Mar 1;86(3):353–360. doi: 10.1097/QAI.0000000000002560

Table 1.

Demographics and health status at baseline (N = 110).

M (SD)
Age 43.2 (8.9)
Time Since HIV Diagnosis (Years) 12.9 (8.6)
Time Since Starting ART (Years) 10.7 (7.2)
CD4+ T-Cell Count (cells/mm3) 641.4 (292.5)
Lipopolysaccharide Binding Protein (ng/ml) 7183.5 (2958.4)
Proviral HIV DNA (copies per 106 cells) 209.7 (1023.8)
N (%)
Race/Ethnicity
 Black/African American 18 (16.4%)
 White 47 (42.7%)
 Hispanic/Latinx 32 (29.0%)
 Other Ethnic Minority 13 (11.8%)
Income
 Up to $4,999 16 (14.7%)
 $5,000 - $11,999 28 (25.7%)
 $12,000 - $15,999 27 (24.8%)
 $16,000 - $24,999 12 (11.0%)
 $25,000 - $34,999 9 (8.3%)
 $35,000 - $49,000 7 (6.4%)
 $50,000 or greater 1 (0.9%)
Education
 Less than High School 8 (7.3%)
 High School Graduate 17 (15.5%)
 Some College/Trade School 57 (51.8%)
 College Graduate 17 (15.5%)
 Any Graduate School 11 (10.0%)
ART Regimen
 INSTI & NRTI 26 (24%)
 Boosted PI & NRTI 31 (28%)
 NRTI & NNRTI 25 (23%)
 PI, NRTI, & NNRTI 2 (2%)
 Other HAART 9 (9%)
 Not HAART 8 (7%)
 No ART 8 (7%)
Undetectable HIV Viral Load ( < 40 copies/mL) 80 (74.1%)
ART Adherence ≥ 90% 51 (46.4%)